Iovance Biotherapeutics, Inc. (IOVA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 02:47PM EDT. Market open.
| Previous close | 11.54 |
| Open | 11.60 |
| Bid | 11.67 x 300 |
| Ask | 11.72 x 100 |
| Day's range | 11.34 - 11.80 |
| 52-week range | 3.21 - 18.33 |
| Volume | |
| Avg. volume | 8,949,877 |
| Market cap | 3.273B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Insider Monkey
20 Counties with the Highest Cancer Rates in the US
In this article, we will be taking a look at the 20 counties with the highest cancer rates in the US. If you do not want to learn about the global impact of cancer, head straight to the 5 Counties with the Highest Cancer Rates in the US. Confronting Cancer: Global Impact and Trends in […]
- Simply Wall St.
Market Sentiment Around Loss-Making Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Iovance Biotherapeutics, Inc. ( NASDAQ:IOVA ) is possibly approaching a major achievement in its business, so we would...
- Zacks
Iovance (IOVA) Stock Surges More Than 60% YTD: Here's Why
Iovance (IOVA) surges on the recent FDA approval for its lead pipeline drug as the first individualized, one-time cell therapy for certain patients with melanoma.
© 2024 Yahoo. All rights reserved.